INNOVATION & PARTNERSHIPS



Where science meets purpose, driving the future of longevity

At Clinique La Prairie, innovation is not just a value, it is the driving force behind our mission to redefine longevity and shape the future of health. For over 90 years, we have been at the forefront of medical breakthroughs, combining visionary research, world-class medical expertise, and strategic partnerships to create real-world solutions that improve healthspan and overall wellbeing.

Our longevity health clinic ecosystem brings together leading researchers, scientific advisors, strategic investors, and pioneering industry partners across Europe and beyond. Together, we work at the intersection of biology, technology, and preventive medicine to develop the next generation of longevity-driven programs, tools, and health solutions.

OUR INNOVATION
ENGINE

At the core of our innovation efforts is the Life Science Team, a group of longevity experts dedicated to translating cutting-edge longevity science into applied, personalized care.

This team is responsible for designing longevity programs and protocols, developing supplements, assessment tools, and new health technologies.

Their mission is to ensure that every solution we offer is rooted in the latest scientific evidence, clinically validated, and optimized for long-term, preventive impact.

Longevity Fund by
Clinique La Prairie

Recently launched, the Longevity Fund is a bold strategic initiative positioning our clinic not only as a leader in longevity solutions but also as a shaper of the field itself.

The fund's vision is to invest in early-stage companies and breakthrough technologies that aim to transform how we age and extend healthspan across the four pillars of longevity.

By bridging scientific exploration with real-world application, the fund demonstrates Clinique La Prairie’s commitment to advancing the frontier of global longevity innovation.

Independent
Scientific Committee

Our independent scientific committee is composed of leading international longevity experts in aging, biosciences, preventive medicine & ethics. This committee ensures that our work remains anchored in strong biomedical evidence and aligned with the world's top research institutions.

The committee:
- Guides our scientific strategies and innovation roadmap
- Provides insight into global longevity research trends
- Upholds the highest standards of scientific rigor and ethical practice

Strategic Innovation
& Medical Partnerships

We collaborate with leading research centers, universities, medical institutions, and technology pioneers. These partnerships accelerate discovery, testing, and the transition from exploratory research to clinically meaningful applications for our guests.

LATEST PARTNERSHIPS
& INVESTMENTS

  • INVESTMENTS | Volumina

    Volumina is a clinical-stage medtech company that has developed AdiPearl™, an injectable biomaterial that naturally regenerates soft tissues and restores facial volume. Using cellulose-based scaffolds, AdiPearl™ stimulates the body to regenerate its own adipose tissue, offering a non-surgical alternative to fat grafting with long-lasting, natural results.

    Clinique La Prairie supports Volumina’s innovation as part of our commitment to advancing longevity science. By partnering with leaders in regenerative medicine, we help bring transformative technologies to market that enhance healthspan, wellbeing, aesthetic rejuvenation, and biological vitality for our guests.

  • PARTNERSHIPS | GlycanAge

    GlycanAge is a biotechnology company and pioneer in the study of IgG glycosylation, a key regulatory mechanism of the immune system. GlycanAge analyzes the sugar structures (glycans) attached to immunoglobulin G (IgG). With this information, they provide insights into how the immune system shifts between pro- and anti-inflammatory states.

    Through its exclusive partnership with Clinique La Prairie, GlycanAge delivers a systemic inflammation score based on the IgG glycan profile. This test provides important insights on low-grade chronic inflammation, a central driver of biological aging and age-related diseases. This collaboration enables us to integrate an advanced, modifiable biomarker of immune aging into our longevity approach, supporting our preventive approach, our monitoring, and facilitating the personalization of interventions.

  • PARTNERSHIPS | Zora Biosciences

    Zora Biosciences is a biotechnology company specialized in lipidomics, with a focus on bioactive lipids, such as ceramides, that play a central role in cardiometabolic health. Their research has contributed to the development of advanced ceramides-based indexes that have greater predictive ability than the traditional cholesterol profile.

    We are the first clinic to offer the CERT2 test, an innovative ceramide-based cardiovascular risk assessment developed by Zora Biosciences. CERT2 analyzes specific ceramide and phospholipid ratios associated with vascular inflammation, plaque instability, and cardiometabolic dysfunction.

  • PARTNERSHIPS | Genknowme

    Genknowme is an epigenetics company based in Lausanne specializing in DNA methylation analysis to assess how lifestyle, environmental factors, physiological stress, and aging influence gene expression.

    Clinique La Prairie has maintained a long-term partnership with Genknowme since 2020, enabling the integration of epigenetic biomarkers into our longevity assessments. Through this collaboration, our longevity clinic has benefited from several exclusivities, including being the first clinic to offer their epigenetic stress test.

    Thanks to this partnership, we also offers the measurement of epigenetic age, providing guests with a molecular indicator of biological aging based on DNA methylation patterns. Beyond diagnostics, the collaboration has expanded to other activities, including Genknowme’s endorsement of Epinome, our Holistic Health supplement to support epigenetic health.

  • PARTNERSHIPS | AudioVitality

    AudioVitality is a Swiss technology company specializing in vibroacoustic sound therapy designed to support wellbeing, recovery, and mental balance. Their proprietary technology is based on highly structured low-frequency sound waves (RubesaSounds®) that generate a dual stimulation: auditory stimulation through the auditory system and vibrotactile stimulation through low-frequency vibrations perceived across the body. This combined stimulation engages both neural and physiological pathways. It facilitates deep relaxation, improves autonomic balance, and enhances recovery.
     
    We were the first partner to introduce AudioVitality technology within a clinical longevity environment. Today, AudioVitality sessions are integrated into several Clinique La Prairie programs where they contribute to stress reduction and vitality.